Role of vasopressin antagonists in the management of acute decompensated heart failure.

Cesare Orlandi*, Christopher A. Zimmer, Mihai Gheorghiade

*Corresponding author for this work

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

Vasopressin antagonists are a class of neurohormonal antagonists with applications in both the short-term and long-term management of patients with acute decompensated heart failure (ADHF). The pharmacologic effects of vasopressin antagonists include changes in fluid balance and hemodynamics that may improve symptoms and outcomes in patients hospitalized with ADHF. With chronic therapy, vasopressin antagonists offer the potential to improve outcomes through a variety of mechanisms, including more effective treatment of congestion, preservation or improvement of renal function, or a reduction in the use of concomitant loop diuretic therapy. Several vasopressin antagonists are currently in advanced clinical trials for the treatment of ADHF, chronic stable heart failure, and hyponatremia.

Original languageEnglish (US)
Pages (from-to)131-139
Number of pages9
JournalCurrent heart failure reports
Volume2
Issue number3
DOIs
StatePublished - Sep 2005

ASJC Scopus subject areas

  • Emergency Medicine
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Role of vasopressin antagonists in the management of acute decompensated heart failure.'. Together they form a unique fingerprint.

  • Cite this